Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer
双重 JAK/HDAC 抑制剂与瑞戈非尼联合使用可协同降低结直肠癌的肿瘤生长、转移和瑞戈非尼诱导的毒性
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-024-03106-8
Prachi Bajpai, Sumit Agarwal, Farrukh Afaq, Sameer Al Diffalha, Darshan S Chandrashekar, Hyung-Gyoon Kim, Abigail Shelton, C Ryan Miller, Santosh K Singh, Rajesh Singh, Sooryanarayana Varambally, Ganji Purnachandra Nagaraju, Ashish Manne, Ravi Paluri, Moh'd Khushman, Upender Manne